The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Balancing the demands of regulatory reform, while maintaining our core business of providing high quality regulation of therapeutic goods in Australia, continues to be both a challenge and a priority.